GLP-1 vs GLP-2 vs Triple Agonists: What's Really Happening…: Summary and Key Moments

Key moments

Tap a moment to play the video from there.

0:00Disclaimer about prescribing authorityMason says he is a chiropractor who cannot prescribe these drugs. He says patients at his clinic are prescribed through a nurse practitioner with slow dose changes.
2:03Naming the three drugsMason lists semaglutide, tirzepatide and retatrutide, calling them GLP-1, GLP-2 and GLP-3 in turn. He says each generation aims to be more effective with fewer side effects.
4:07What each generation addsMason describes one mechanism for the first drug, two for the second and three for the third. He says the third also mobilizes body fat and, in particular, visceral fat.
5:09What patients think the drugs doKim says patients mostly talk about losing food noise and appetite, and worry about constipation and nausea. Mason says the drugs do much more behind the scenes.
6:11Side effects in research versus clinicMason says nausea is the most common side effect in the research across all three. Kim says her patients report less nausea and better bowel habits on the third drug.
8:43The drug is a toolKim says the answer is lifestyle change, not the medication. She describes coaching on balanced plates, three meals a day, protein and exercise.
10:45Muscle loss without lifestyle changesKim says patients who rely only on the drug can lose a lot of muscle along with fat. She says this leaves them with worse blood sugar handling and weaker bones and tendons.
12:16Monitoring body compositionMason says the clinic weighs patients weekly and does a monthly body scan. The aim, he says, is to lose fat while keeping lean muscle.
14:48Protein and resistance training basicsKim recommends 20 to 30 grams of protein with every meal and snack. She suggests starting resistance work with walking, a weighted vest or bands.
16:52Sleep, hydration and the clinic's stanceKim covers sleep, water and electrolytes. Mason ends by saying the clinic provides these drugs only with coaching and wants patients eventually off them.

What the video says

Dr. Josh Mason opens by saying he is a chiropractor who cannot prescribe these drugs. He says the patients at his clinic, Active Health, receive them through an on-staff nurse practitioner. His co-host Kim Mason, a registered nurse and functional medicine coach, works with those patients on lifestyle changes.

The first half compares three drugs. Mason uses informal labels: he calls semaglutide "GLP-1", tirzepatide "GLP-2" and retatrutide "GLP-3". He says each generation adds mechanisms. According to Mason, the first mainly reduces appetite and slows the gut. The second adds more blood sugar control and insulin effects. The third adds fat mobilization, a higher metabolic rate and, he says, a reduction in visceral fat. He says trials show more weight loss with each generation. Kim says patients mostly notice reduced "food noise". On side effects, Mason says nausea is the most common complaint in the research across all three. In their own patients, Kim reports less nausea and constipation on the third drug and a milder appetite effect, which she sees as a good thing. Mason adds that someone whose main complaint is food noise might still do better on the first drug.

The second half is the main message of the episode. Kim says the drug "is a tool" and that lasting results come from changing daily habits. She names muscle loss as the biggest risk of using the drugs without lifestyle changes. She says that when people under-eat, the body draws on muscle before fat, so the scale can fall while body composition worsens. The clinic weighs patients weekly and runs a body scan monthly to watch for this. Kim's practical advice includes 20 to 30 grams of protein with every meal and snack, three meals a day, and resistance training. She suggests starting small with walking, a weighted vest or resistance bands. She also stresses sleep, water and electrolytes.

The episode closes with the clinic's stance that nobody gets these drugs there without coaching. The hosts say the goal is for patients to eventually come off the drug while keeping their habits. The talk is a clinic's own perspective, not a trial review.

On each compound

Semaglutide 2:03

Mason names semaglutide as the first-generation drug, which he calls GLP-1. He says its main effect is on appetite, through satiety signals and slower gut motility, and that someone whose main complaint is food noise might do well on it.

See how your DNA reads Semaglutide

Tirzepatide 2:03

Mason refers to tirzepatide as the second-generation drug, which he labels GLP-2. He says it adds more blood sugar control and insulin effects on top of the appetite effect.

See how your DNA reads Tirzepatide

Retatrutide 2:03

Mason calls retatrutide the third-generation drug, which he labels GLP-3. He says it adds fat mobilization and a higher metabolic rate, and Kim says her patients report less nausea and a gentler appetite effect on it.

See how your DNA reads Retatrutide

“the GLP is not the answer. It's a tool.”
Active Health Podcast with Dr. Josh Mason 8:43

What this video doesn’t settle

The hosts run a clinic that coaches patients on these drugs, so the episode reflects their business model and has no outside voice or comparison group.
Mason refers to trials showing more weight loss with each generation, but gives no study names, figures or doses.
The comparison of side effects between drugs rests on Kim's impressions of her own patients, not on measured data.

Questions this video answers

What is the difference between GLP-1, GLP-2 and GLP-3 drugs according to this podcast?

Mason uses these informal labels for semaglutide, tirzepatide and retatrutide. He says the first mainly lowers appetite, the second adds more blood sugar control, and the third also mobilizes body fat and raises metabolic rate.

Why do the hosts say muscle loss matters on GLP-1 type drugs?

Kim says that in a calorie deficit the body finds energy in muscle before fat. She says people who rely only on the drug can end up with worse body composition and less protection for bones and tendons, even if the scale looks better.

What lifestyle habits does Kim Mason recommend while using these drugs?

Kim recommends three meals a day, 20 to 30 grams of protein with every meal and snack, and resistance training. She says to start small with walking, a weighted vest or resistance bands, and to keep up sleep, water and electrolytes.

Do the hosts say retatrutide has fewer side effects than semaglutide?

Mason says the research shows nausea is the most common side effect and is consistent across all three drugs. Kim says that in their clinic patients on the third drug report less nausea and constipation, which is her own observation.